Therapeutic implications of the new biology

A multicenter pilot study of nivolumab with drug-eluting bead transarterial chemoembolization in patients with liver-limited hepatocellular carcinoma.

ESMO gastrointestinal oncology·2026

Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301.

ESMO open·2026

Quantitative benefit-risk assessment of data from the phase III ClarIDHy study of ivosidenib versus placebo in patients with mIDH1 cholangiocarcinoma.

ESMO gastrointestinal oncology·2026

Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance).

ESMO open·2025

An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.

ESMO open·2024

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Basic and Translational Research Advances in NSCLC.

Cancer journal (Sudbury, Mass.)·2026

Medical Management of Non-Small Cell Lung Cancer Brain Metastases in the Modern Era.

Cancer journal (Sudbury, Mass.)·2026

Optimizing the Care of Patients With Locally Advanced NSCLC With Multimodality Therapy.

Cancer journal (Sudbury, Mass.)·2026

Early-Stage NSCLC: Novel Surgical Techniques and Neoadjuvant, Adjuvant, and Perioperative Therapies.

Cancer journal (Sudbury, Mass.)·2026

Lung Cancer Biomarker Testing: IHC, Tissue Genomics, Digital Pathology, and ctDNA.

Cancer journal (Sudbury, Mass.)·2026

The Quest to Cure Metastatic Non-Small Cell Lung Cancer With Immunotherapy.

Cancer journal (Sudbury, Mass.)·2026

Radiocopper in BCMA-targeted immunotheranostics of myeloma.

Theranostics·2026

hNET-targeted [18F]MFBG PET as baseline functional imaging in newly diagnosed neuroblastoma.

Theranostics·2026

Nano-flow intracalvariosseous infusion enables skull-to-brain delivery of BBB-impermeable molecular and nanoscale agents in mice and rabbits.

Theranostics·2026

Design of a Pragmatic Randomized Controlled Trial for Comparing the Michigan Screening and Intervention for Glaucoma and Eye Health and Telemedicine Protocol with Usual Care for Disease Detection.

Clinical ophthalmology (Auckland, N.Z.)·2026

Erratum: Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy: Erratum.

Theranostics·2026

Correction: Editorial: Advancements in meningioma management: from imaging techniques to personalized medicine approaches.

Frontiers in neurology·2026

Related Experiment Videos

Therapeutic implications of the new biology

Related Concept Videos

A multicenter pilot study of nivolumab with drug-eluting bead transarterial chemoembolization in patients with liver-limited hepatocellular carcinoma.

Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301.

Quantitative benefit-risk assessment of data from the phase III ClarIDHy study of ivosidenib versus placebo in patients with mIDH1 cholangiocarcinoma.

Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance).

An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.

Basic and Translational Research Advances in NSCLC.

Medical Management of Non-Small Cell Lung Cancer Brain Metastases in the Modern Era.

Optimizing the Care of Patients With Locally Advanced NSCLC With Multimodality Therapy.

Early-Stage NSCLC: Novel Surgical Techniques and Neoadjuvant, Adjuvant, and Perioperative Therapies.

Lung Cancer Biomarker Testing: IHC, Tissue Genomics, Digital Pathology, and ctDNA.

The Quest to Cure Metastatic Non-Small Cell Lung Cancer With Immunotherapy.

Radiocopper in BCMA-targeted immunotheranostics of myeloma.

hNET-targeted [18F]MFBG PET as baseline functional imaging in newly diagnosed neuroblastoma.

Nano-flow intracalvariosseous infusion enables skull-to-brain delivery of BBB-impermeable molecular and nanoscale agents in mice and rabbits.

Design of a Pragmatic Randomized Controlled Trial for Comparing the Michigan Screening and Intervention for Glaucoma and Eye Health and Telemedicine Protocol with Usual Care for Disease Detection.

Erratum: Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy: Erratum.

Correction: Editorial: Advancements in meningioma management: from imaging techniques to personalized medicine approaches.

Related Experiment Videos

Therapeutic implications of the new biology

Related Concept Videos

Related Articles